Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Routine Clinical Care in Patients With Epilepsy

NCT02736162 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT02736162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Routine Clinical Care in Patients With Epilepsy
Lead sponsor
Eisai Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
July 31, 2016
Enrollment
61 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial-onset seizures, primary generalized tonic-clonic seizures